BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang T, Wang SC, Ye L, Maimaitiyiming Y, Naranmandura H. Targeting Viral Proteins for Restraining SARS-CoV-2: Focusing Lens on Viral Proteins Beyond Spike for Discovering New Drug Targets. Expert Opin Drug Discov 2023. [PMID: 36723288 DOI: 10.1080/17460441.2023.2175812] [Reference Citation Analysis]
2 Zareei S, Pourmand S, Amanlou M. Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.996005] [Reference Citation Analysis]
3 Odolczyk N, Klim J, Podsiadła-białoskórska M, Winiewska-szajewska M, Szolajska E, Zielenkiewicz U, Poznański J, Zielenkiewicz P. Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2. Front Mol Biosci 2022;9:983014. [DOI: 10.3389/fmolb.2022.983014] [Reference Citation Analysis]